Difference between papillary and follicular thyroid carcinoma outcomes: an experience from Egyptian institution
- PMID: 25859412
- PMCID: PMC4383844
- DOI: 10.7497/j.issn.2095-3941.2015.0005
Difference between papillary and follicular thyroid carcinoma outcomes: an experience from Egyptian institution
Abstract
Objective: Differentiated thyroid carcinomas (DTCs) are classified into papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC). DTCs are analyzed as a single group in clinical studies that investigated the prognostic factors and prognosis of these malignancies. However, the biological behaviors of these carcinomas significantly differ. In the present study, we aimed to detect differences in the outcomes between PTC and FTC in Mansoura University Hospital in Egypt.
Methods: A total of 558 patients with histologically proven thyroid carcinomas from January 2003 to December 2012 were retrospectively enrolled. The clinical and pathological data of patients were reviewed.
Results: Large primary tumor size, lymph node involvement, extrathyroid extension, and distant metastasis were significant poor prognostic factors for overall survival (OS) in old PTC patients. Cox hazard analysis showed that the patient's age, extra thyroid extension, and distant metastasis were the only independent prognostic factors. In FTC patients, only the distant metastasis and degree of tumor invasion were significant poor prognostic factors in OS univariate analysis. However, these factors were nonsignificant in multivariate analysis. The 10-year OS rates were 97% and 89% for PTC and FTC, respectively (P=0.003). The 10-year disease-free survival (DFS) rates were 77.2% in PTC vs. 65% in FTC (P=0.179).
Conclusion: The significant prognostic factors vary between the two types of DTCs. Therefore, PTC and FTC patients need to be analyzed and reported independently. PTC survival is widely and significantly affected by age, extrathyroid extension, and distant metastasis. By contrast, these factors were nonsignificant in FTC, which showed poorer survival than PTC.
Keywords: Egypt; Thyroid cancer; differentiated thyroid; follicular; papillary.
Conflict of interest statement
No potential conflicts of interest are disclosed.
Figures
References
-
- Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787–803. - PubMed
-
- Hu MI, Vassilopoulou-Sellin R, Lustig R, Lamont JP. In: Cancer Management: A Multidisciplinary Approach. 11 eds. Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, editors. Manhasset, NY: CMP Medica; 2008. Thyroid and Parathyroid Cancers.
-
- Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein HC. Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab. 2004;89:3668–3676. - PubMed
-
- Livolsi VA, Albores-Saavedra J, Asa SL. In: Pathology and Genetics of Tumors of the Endocrine Organs. DeLellis RA, Lloyd R, LiVolsi VA, Eng C, editors. World Health Organization Classification of Tumors. Lyon: IARC Press; 2004. Papillary carcinoma; pp. 57–66.
-
- Volante M, Landolfi S, Chiusa L, Palestini N, Motta M, Codegone A, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer. 2004;100:950–957. - PubMed
LinkOut - more resources
Full Text Sources